Category: tocilizumab
Tocilizumab - ROACTEMRA 162 mg, solution injectable en seringue préremplie
Tocilizumab ROACTEMRA 162 mg, solution injectable en seringue préremplie - L04AC07 ROCHE REGIS
View DetailsTocilizumab - ROACTEMRA 20 mg/ml, solution à diluer pour perfusion
Tocilizumab ROACTEMRA 20 mg/ml, solution à diluer pour perfusion - L04AC07 ROCHE REGISTRATION
View DetailsROACTEMRA 162 MG INJ SRG 0,9 ML (Tocilizumab)
ROACTEMRA 162 MG INJ SRG 0,9 ML (Tocilizumab) - Maladie rare sans désignation orpheline *Treatmen
View DetailsROACTEMRA 20 MG/ML INJ FL 10 ML (Tocilizumab)
ROACTEMRA 20 MG/ML INJ FL 10 ML (Tocilizumab) - Maladie rare sans désignation orpheline *Treatmen
View DetailsROACTEMRA 20 MG/ML INJ FL 20 ML (Tocilizumab)
ROACTEMRA 20 MG/ML INJ FL 20 ML (Tocilizumab) - Maladie rare sans désignation orpheline *Treatmen
View DetailsROACTEMRA 20 MG/ML INJ FL 4 ML (Tocilizumab)
ROACTEMRA 20 MG/ML INJ FL 4 ML (Tocilizumab) - Maladie rare sans désignation orpheline *Treatment
View DetailsTOCILIZUMAB ACTEMRA 21 J 068
N°ENREGISTREMENT : 128/ 21 J 068 /15 Code : 21 J 068 DENOMINATION COMMUNE INTERNATIONALE : TOC
View Details